김완준 교수의 진료시간표

김완준 교수의 상세정보

• 1999 .03  ~  2005 .02  :  울산대학교 의과대학 졸업
• 2016 .03  ~  2018 .02  :  울산대학교 대학원 의학과 석사
• 2018 .03  ~  2020 .02  :  울산대학교 대학원 의학과 박사

• 2005 .02  ~  2006 .02  :  울산대학교 서울아산병원 인턴
• 2006 .02  ~  2010 .02  :  울산대학교 서울아산병원 전공의
• 2013 .02  ~  2017 .02  :  울산대학교 서울아산병원 전임의
• 2017 .02  ~  2020 .02  :  고려대학교 구로병원 임상조교수
• 2020 .02  ~   :  고려대학교 구로병원 임상부교수

•  ~   :  대한간암학회 정회원
•  ~   :  대한이식학회 정회원
•  ~   :  대한내시경복강경학회 정회원

• [SCI] (Updated Status of Deceased-Donor Liver Graft Allocation for High-Urgency Adult Patients in a Korean High-Volume Liver Transplantation Center)
• [SCI] (Pure Laparoscopic Versus Open Right Hepatectomy for Hepatocellular Carcinoma in Patients With Cirrhosis A Propensity Score Matched Analysis)
• [SCI] (Surgical outcomes following laparoscopic major hepatectomy for various liver diseases)
• [SCI] (Clinicopathological Features and Prognosis of Intrahepatic Cholangiocarcinoma After Liver Transplantation and Resection)
• [SCI] (ABO-Incompatible Adult Living Donor Liver Transplantation Under the Desensitization Protocol With Rituximab)
• [SCI] (Effect of Reoperation on Long-Term Outcome of pT1b/T2 Gallbladder Carcinoma After Initial Laparoscopic Cholecystectomy)
• [SCI] (Clinicopathological Features and Long-Term Outcomes of Intraductal Papillary Neoplasms of the Intrahepatic Bile Duct)
• [SCI] (Donor Safety and Recipient Liver Function After Right-Lobe Liver Transplantation From Living Donors With Gilbert Syndrome)
• [SCI] (Longterm Prognosis of Combined Hepatocellular Carcinoma-Cholangiocarcinoma Following Liver Transplantation and Resection)
• [SCI] (Portal vein stenting as a significant risk factor for biliary stricture in adult living donor liver transplantation)
• [SCI] (Totally laparoscopic anatomical liver resection for centrally located tumors: A single center experience.)
• [SCI] (Initial outcomes of pure laparoscopic living donor right hepatectomy in an experienced adult living donor liver transplant center.)
• [SCI] (A Pilot Study of the Pharmacokinetics of the Modified-Release Once-Daily Tacrolimus Formulation Administered to Living-Donor Liver Transplant Recipients.)
• [SCI] (Preoperative prognostic values of α-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-II) in patients with hepatocellular carcinoma for living donor liver transplantation.)
• [SCI] (In Situ Split Liver Transplantation for 2 Adult Recipients: A Single-Center Experience.)
• [SCI] (Laparoscopic Versus Open Liver Resection for Centrally Located Hepatocellular Carcinoma in Patients With Cirrhosis: A Propensity Score-matching Analysis.)

최종수정일 : 2020.09.22